Chair of Oncology inducted into Order of Canada

A renowned breast cancer researcher and Chair of Oncology at the Michael G. DeGroote School of Medicine has been inducted into the Order of Canada.

May 16, 2017

Order of Canada Investiture Ceremony
Mark Levine, left, with Governor General David Johnston in Ottawa.

A renowned breast cancer researcher and Chair of Oncology at the Michael G. DeGroote School of Medicine has been inducted into the Order of Canada.

Mark Levine was inducted as a Member of the Order May 12 by Governor General David Johnston in a ceremony in Ottawa.

Throughout his career, Levine has been an active researcher in clinical trials and health services research. His focus is in the areas of breast cancer and venous thromboembolism. Numerous clinical trials he has conducted have impacted health care in Canada and internationally.

A first-generation Canadian, Levine told the Hamilton Spectator that his parents were extremely excited about the investiture, which was announced last year.

“My mother made the most deal…she said there was a reason for her to have left Poland, so her son could get the Order of Canada…she cried.”

Three rows of students in a happy group picture at iGEM 2025, holding up a plaque with McMaster University's name on it

McMaster iGEM team wins gold medal for at-home test that signals transplant rejection

One of 400 teams at the international synthetic biology competition, the students presented their at-home kit that offers an early warning if the body is rejecting a kidney transplant, allowing for timely interventions.
An out-of-focus patient in the background is connected to a ventilator, in the foreground

Inexpensive drug that prevents bleeding could save thousands of dollars in care

Giving ventilated ICU patients pantoprazole, which costs as little as 50 cents a day, prevents complications that prove costly for patients' health and health-care systems.
Eric Brown beside a tree trunk with fungi growing on it.

Recent awards power two new studies into drug discovery and development  

Backed by premier research funding programs, the collaborations between McMaster and Kapoose Creek Bio will fast-track the development of an all-new drug candidate that targets neurological conditions, like depression.